Drawing for LEAKSENZE

USPTO serial 79406021

LEAKSENZE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MANCA, ALBERTO I
Law office
TMEG LAW OFFICE 108

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with LEAKSENZE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elias Hantula

492 Wood Ridge AveWood Ridge, NJ 07075United States

Goods and services

ClassDescriptionStatusFirst use
009Computer software applications, downloadable, for monitoring intravenous infusion sites and detecting intravenous physiological changes; computer programs, downloadable, for monitoring intravenous therapy and generating alerts for intravenous physiological changes; downloadable applications for use with mobile devices for real-time medical monitoring of infusion-related conditions; downloadable software and applications for mobile devices for transmitting and analyzing intravenous monitoring data; downloadable software for cloud servers for collecting, storing, and analyzing data from patient infusion monitoring systems; wearable computer peripherals; wearable computers; smartwatches; wearable video display monitors; data processing equipment, namely, electronic medical data readers; alarm installations; alarm monitoring systems; alarm sensors; electronic sensors for measuring tissue swelling, intravenous physiological changes, and pressure at intravenous infusion sites; downloadable communication software for transmitting patient monitoring alerts and data; computer hardware, namely, communications servers; apparatus and instruments for recording, transmitting, reproducing or processing sound, images or data; downloadable data communications software for transmitting and processing intravenous monitoring data; data processing systems comprised of computers, microprocessors, and electronic sensors for medical monitoring; downloadable computer software for application and database integration; data collection apparatus being data processing apparatus; data communications computer hardwareACTIVE—
010Medical diagnostic apparatus, namely, electronic devices for monitoring intravenous infusion sites and detecting infusion-related physiological responses; wearable monitors used to measure biometric data for medical purposes; measurement apparatus, namely, patient monitoring sensors for medical purposes; intravenous catheters; electronic blood pressure measuring apparatus for medical use; measurement apparatus, namely, sensors for medical purposes, for measuring tissue swelling, infusion-related conditions, and pressure at intravenous infusion sites.ACTIVE—
042calibration services, namely, Calibration of sensors; calibration services, namely, calibration of detectors; calibration services, namely, calibration of measuring apparatus; medical research; scientific research for medical purposes; software as a service (SAAS) services featuring software for intravenous infusion sites, detecting infusion-related conditions, and transmitting medical alerts; design and development of computer software for use with medical technology; design and development of medical diagnostic apparatus; design and development of medical technology; development of software applications; consultancy relating to software for communication systems; consultancy in the field of software as a service (SAAS); consultancy relating to pharmaceutical research and developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Mar 19, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 2, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 2, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Dec 16, 2025MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Dec 16, 2025ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 27, 2025RFNTREFUSAL PROCESSED BY IB—
Jun 3, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 20, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 20, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 17, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 17, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 9, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2025DOCKASSIGNED TO EXAMINER—
Oct 9, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 9, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 3, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance